BUFFALO, NY--(MARKET WIRE)--Aug 27, 2007 -- Cleveland BioLabs, Inc. (NasdaqCM:CBLI - News) (NasdaqCM:CBLI - News) today announced that the Company’s application for upgrade of its listing from NASDAQ Capital Market to NASDAQ Global Market was approved. The Company’s shares will begin trading on NASDAQ Global Market under the same symbol (CBLI), effective August 28, 2007.
